GUAIFENESIN AND DEXTROMETHORPHAN 100 mg-10 mg/5 mL
Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
14,450 recalls · Class II, newest first
Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.
Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Reason CGMP Deviations: Manufacturing deviations were reported due to an abnormal appearance on parts of machinery.
Reason Failed Tablet/Capsule Specification; oversized tablet found in a bottle
Reason CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities.
Reason Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.
Reason Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.
Reason Microbial contamination of non-sterile product.
Reason Microbial contamination of non-sterile product.
Reason Microbial contamination of non-sterile product.
Reason Lack of Assurance of Sterility
Reason Lack of Assurance of Sterility
Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits